Atherosclerosis: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • Atheroscler Open Access 2016, Vol 1(1): 102

Novel Cell Replacement Strategies for Heart Failure Treatment

Tamer MA Mohamed*
Cardiovascular Research Institute, Faculty of Medical and Human Sciences, The University of Manchester, United Kingdom
*Corresponding Author : Tamer MA Mohamed, Cardiovascular Research Institute, Faculty of Medical and Human Sciences, The University of Manchester, United Kingdom, Tel: 001-415-9711459, Email: Tamer.Mohamed@Manchester.ac.uk

Received Date: Nov 09, 2015 / Accepted Date: Dec 03, 2015 / Published Date: Dec 10, 2015

Citation: Mohamed TMA (2015) Novel Cell Replacement Strategies for Heart Failure Treatment. Atheroscler open access 1: 102.

Copyright: © 2015 Mohamed TM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Review summary

  1. Asifa
    Posted on Aug 24 2016 at 3:54 pm
    The article describes the role of cell replacement in the treatment of myocardial infraction and heart failure. The approach involves replacement of the damaged cardiomycetes with stem cells or pluripotent stem cell derived cardiomycetes for the complete recovery of structure and function of the heart cells. The article provides insights into this novel method and will help in the development of new and highly advanced methods of treatment of cardiovascular diseases.
Top